Linda Dong

Director at Astrana Health and Fulgent Genetics

As of Nov 10, 2026: Linda Dong (Director, ASTH) reported no shares bought or sold themselves in the last 12 months (Form 4). ASTH's Quality Score is 5. Scores as of 11:01 PM ET, 15 minutes behind.

No shares they bought or sold themselves in the last 12 months. Their newest Form 4, for Jun 10: stock award (4,525 ASTH shares).

Bought$012 months Sold$012 months Last filedJun 10stock award

From SEC Form 4s · Insiders have 2 business days to file a trade

Every trade Linda Dong reported

None in the last 12 months, as filed.

Every Form 4 Linda Dong filed, as filed, on EDGAR

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See ASTH's 14 chart checksSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Linda Dong's companies

2 companies, with each stock's Quality Score

Stock	Title, as filed	Trades	Quality Score
ASTHAstrana HealthDirector	Directortitle as of Jun 12	0	5
FLGTFulgent GeneticsDirector	Directortitle as of May 18	0	6

Alerts for Linda Dong

An email for each Form 4 Linda Dong files at any of the 2 companies, with each stock's Quality Score.

Set an alert

A free account. No card.

Use this page

Kept by Andrew Gomes, Breakaway's founder, from the SEC's Form 4 filings. Updated Jun 10, 2026.

Their filings on the SEC's site

Free to reuse with a link to this page.

How to cite

Breakaway, Linda Dong: Director at Astrana Health (ASTH), Jun 10, 2026, getbreakaway.com/insiders/linda-dong

Journalists: email support@getbreakaway.com for the data behind this page.

Others who file at their companies

Astrana Health

Fulgent Genetics

Insider trades by person